PBI News
Pitney Bowes Inc.
$17.00
+$0.06(+0.35%)
62
Overall
80
Value
60
Tech
47
Quality
Market Cap
$2.32B
Volume
988.02K
52W Range
$8.95 - $19.07
Target Price
$19.30
PBI news: the latest Pitney Bowes Inc. headlines, press releases and market updates, newest first.
Latest PBI News
- Paradigm Biopharmaceuticals Options to Expire Unexercised Amid Voluntary AdministrationTipRanks Australian Auto-Generated Newsdesk · Oct 12, 2026
- Paradigm Biopharmaceuticals Redeems Over 1.1 Million Convertible NotesTipRanks Australian Auto-Generated Newsdesk · Oct 8, 2026
- Paradigm Biopharmaceuticals Shares Suspended as ASX Flags Financial BreachTipRanks Australian Auto-Generated Newsdesk · Sep 30, 2026
- Paradigm Biopharmaceuticals Cancels 2 Million Convertible NotesTipRanks Australian Auto-Generated Newsdesk · Sep 24, 2026
- Paradigm Returns US$2m to Obsidian Amid Phase 3 Trial ReviewTipRanks Australian Auto-Generated Newsdesk · Sep 24, 2026
- Paradigm Biopharmaceuticals Halts Trading Pending Phase 3 Trial UpdateTipRanks Australian Auto-Generated Newsdesk · Sep 22, 2026
- Paradigm Biopharmaceuticals reshapes medical leadership as Phase 3 osteoarthritis trial advancesTipRanks Australian Auto-Generated Newsdesk · Sep 15, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PBI | $17.00 | +0.4% | 988.02K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |